Thermographic study of in vivo modulation of vascular responses to phenylephrine and endothelin-1 by dexamethasone in the horse

被引:17
作者
Cornelisse, CJ [1 ]
Robinson, NE [1 ]
Berney, CA [1 ]
Eberhart, S [1 ]
Hauptman, JE [1 ]
Derksen, FJ [1 ]
机构
[1] Michigan State Univ, Dept Large Anim Clin Sci, Coll Vet Med, E Lansing, MI 48823 USA
关键词
horse; dexamethasone; endothelin; intradermal; phenylephrine; thermography; vascular function;
D O I
10.2746/042516406776563251
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Reasons for performing study: In vitro, glucocorticoids potentiate vasoconstriction of equine digital vessels to catecholamines and this has been implicated as a mechanism of glucocorticoid-induced laminitis. This observation has never been confirmed in vivo. Objectives: To study the effects of glucocorticoid therapy on vasoconstrictor responsiveness in the horse in vivo. Methods: In a blinded, randomised cross-over experiment, 9 horses were treated with either dexamethasone (0.1 mg/kg bwt i.v.. q. 24 h) or saline i.v. for 6 days. The changes in local average skin temperature before (baseline) and after intradermal injections of the alpha(1)-adrenoceptor agonist phenylephrine (PHE; 10(-4), 10(-5), 10(-6), 10(-7) and 10(-8) mol/l), endothelin-1 (ET-1; 10(-5), 10(-6), 10(-7), 10(-8) and 10(-9) mol/l) or ET-1 plus a blocker (BQ-123 10(-6) mol/l; RES-701 10(-6) mol/l; and L-NAME 10(-4) mol/l) were investigated with a thermograph. Results: Dexamethasone (DEX) decreased baseline skin temperatures, suggesting reduced blood flow as a consequence of an increase in vasomotor tone. This was accompanied by potentiation of the response to PHE as demonstrated by a left shift in the dose-response curve and a decrease in the EC50. Dexamethasone did not potentiate ET-1, but the interplay with the lower baseline temperature resulted in a significantly lower skin temperature for this vasoconstrictor after DEX. The different ET-1 blockers had no effect on ET-I modulated skin temperatures. Conclusions: Dexamethasone decreases skin perfusion. This is accompanied by a potentiated alpha(1)-adrenoceptor agonist response and a greater response to ET-1. Potential relevance: Glucocorticoid therapy probably decreases perfusion of the equine hoof. During disease states that already are characterised by hypoperfusion and/or increased levels of circulating catecholamines, glucocorticoid therapy could, according to the vascular model of laminitis, tilt the balance in favour of laminitis.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 55 条
[1]   THE CUTANEOUS CORTICOSTEROID VASOCONSTRICTION ASSAY - A REFLECTANCE SPECTROSCOPIC AND LASER-DOPPLER FLOWMETRIC STUDY [J].
ANDERSEN, P ;
MILIONI, K ;
MAIBACH, H .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (06) :660-665
[2]   Spasmogenic action of endothelin-1 on isolated equine pulmonary artery and bronchus [J].
Benamou, AEM ;
Marlin, DJ ;
Callingham, BC ;
Hiley, RC ;
Lekeux, P .
EQUINE VETERINARY JOURNAL, 2003, 35 (02) :190-196
[3]   Skin temperature changes and changes in skin blood flow monitored with laser Doppler flowmetry and imaging: A methodological study in normal humans [J].
Bornmyr, S ;
Svensson, H ;
Lilja, B ;
Sundkvist, G .
CLINICAL PHYSIOLOGY, 1997, 17 (01) :71-81
[4]  
Bowen IM, 2004, J HEART VALVE DIS, V13, P593
[5]   CUTANEOUS VASOCONSTRICTOR RESPONSE TO GLUCOCORTICOIDS IN ASTHMA [J].
BROWN, PH ;
TEELUCKSINGH, S ;
MATUSIEWICZ, SP ;
GREENING, AP ;
CROMPTON, GK ;
EDWARDS, CRW .
LANCET, 1991, 337 (8741) :576-580
[6]   Comparison of thermography and laser Doppler imaging in the assessment of Raynaud's phenomenon [J].
Clark, S ;
Dunn, G ;
Moore, T ;
Jayson, M ;
King, TA ;
Herrick, AL .
MICROVASCULAR RESEARCH, 2003, 66 (01) :73-76
[7]   Role of nitric oxide in the regulation of microvascular perfusion in human skin in vivo [J].
Clough, GF .
JOURNAL OF PHYSIOLOGY-LONDON, 1999, 516 (02) :549-557
[8]  
Cornelisse CJ, 2004, EQUINE VET EDUC, V16, P90, DOI 10.1111/j.2042-3292.2004.tb00273.x
[9]   The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1 [J].
Di Filippo, C ;
Rossi, F ;
Ongini, E ;
Del Soldato, P ;
Perretti, M ;
D'Amico, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03) :1133-1141
[10]   THE ROLE OF NITRIC-OXIDE IN THE RESPONSES OF EQUINE DIGITAL VEINS TO VASODILATOR AND VASOCONSTRICTOR AGENTS [J].
ELLIOTT, J ;
BRYANT, CE ;
SOYDAN, J .
EQUINE VETERINARY JOURNAL, 1994, 26 (05) :378-384